Literature DB >> 17028590

RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20.

Manuel de la Mata1, Alberto R Kornblihtt.   

Abstract

Previous studies have linked the C-terminal domain (CTD) of RNA polymerase II (pol II) with cotranscriptional precursor messenger RNA processing, but little is known about the CTD's function in regulating alternative splicing. We have examined this function using alpha-amanitin-resistant pol II CTD mutants and fibronectin reporter minigenes. We found that the CTD is required for the inhibitory action of the serine/arginine-rich (SR) protein SRp20 on the inclusion of a fibronectin cassette exon in the mature mRNA. CTD phosphorylation controls transcription elongation, which is a major contributor to alternative splicing regulation. However, the effect of SRp20 is still observed when transcription elongation is reduced. These results suggest that the CTD promotes exon skipping by recruiting SRp20 and that this contributes independently of elongation to the transcriptional control of alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028590     DOI: 10.1038/nsmb1155

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  82 in total

1.  Transcription and splicing: when the twain meet.

Authors:  Yehuda Brody; Yaron Shav-Tal
Journal:  Transcription       Date:  2011 Sep-Oct

2.  The RNA polymerase C-terminal domain: a new role in spliceosome assembly.

Authors:  Charles J David; James L Manley
Journal:  Transcription       Date:  2011 Sep-Oct

3.  TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Authors:  Marta Montes; Alexandre Cloutier; Noemí Sánchez-Hernández; Laetitia Michelle; Bruno Lemieux; Marco Blanchette; Cristina Hernández-Munain; Benoit Chabot; Carlos Suñé
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

4.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.

Authors:  Stéphanie Solier; Jennifer Barb; Barry R Zeeberg; Sudhir Varma; Mike C Ryan; Kurt W Kohn; John N Weinstein; Peter J Munson; Yves Pommier
Journal:  Cancer Res       Date:  2010-09-03       Impact factor: 12.701

5.  Chromatin density and splicing destiny: on the cross-talk between chromatin structure and splicing.

Authors:  Schraga Schwartz; Gil Ast
Journal:  EMBO J       Date:  2010-04-20       Impact factor: 11.598

6.  First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal.

Authors:  Manuel de la Mata; Celina Lafaille; Alberto R Kornblihtt
Journal:  RNA       Date:  2010-03-31       Impact factor: 4.942

7.  Genetic organization, length conservation, and evolution of RNA polymerase II carboxyl-terminal domain.

Authors:  Pengda Liu; John M Kenney; John W Stiller; Arno L Greenleaf
Journal:  Mol Biol Evol       Date:  2010-06-17       Impact factor: 16.240

8.  Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation.

Authors:  Joanna Y Ip; Dominic Schmidt; Qun Pan; Arun K Ramani; Andrew G Fraser; Duncan T Odom; Benjamin J Blencowe
Journal:  Genome Res       Date:  2010-12-16       Impact factor: 9.043

Review 9.  The RNAissance family: SR proteins as multifaceted regulators of gene expression.

Authors:  Jonathan M Howard; Jeremy R Sanford
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-08-22       Impact factor: 9.957

Review 10.  Dynamic integration of splicing within gene regulatory pathways.

Authors:  Ulrich Braunschweig; Serge Gueroussov; Alex M Plocik; Brenton R Graveley; Benjamin J Blencowe
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.